3 not yet recruiting, 1 completed. 2 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 3 | 2 | Not yet recruiting 2 |
| Phase 1 | 1 | Completed 1 |
Follow LEAF4Life, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Preoperative RAdiation Therapy With Concomitant Liposomal Transcrocetin (L-TC) in Soft tISsue Sarcomas Administration of L-TC, HFRT alone - Sarcoma | Phase 2 | Not yet recruiting | Centre Paul Strauss | 42 | 2026-07-01 | 2026-06-04 |
| Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients Administration of L-TC, Radiotherapy plus Temozolomide - Glioblastoma | Phase 3 | Not yet recruiting | Institut de cancérologie Strasbourg Europe | 554 | 2025-01-01 | 2024-06-27 |
| Efficacy and Safety of LEAF-4L6715 for Acute Respiratory Distress Syndrome LEAF-4L6715, Supportive Care - Acute Respiratory Distress Syndrome | Phase 3 | Not yet recruiting | LEAF4Life, Inc. | 310 | 2024-11-01 | 2024-10-15 |
| A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes LEAF-4L6715 - COVID19, Sepsis or Other Causes, Acute Respiratory Distress Syndrome | Phase 1 / Phase 2 | Completed | Institut de cancérologie Strasbourg Europe | 37 | 2020-04-14 | 2021-12-16 |
Hypoxia (2) · Respiratory Distress Syndrome (2) · Brain Neoplasms (1) · COVID-19 (1) · Glioblastoma (1) · Sarcoma (1) · Sepsis (1)
Palliative Care (1) · Radiotherapy (1) · Temozolomide (1)
France (4)
Alain Combes, MD (1) · Clet Niyikiza, Ph.D. (1) · Marie Claude Morice, Ph.D. (1)